$NBIS is a winner. Can't you see it? Too many FinTwit thesis, wasted words. Jensen has SCREAMED it to you. He knew Arkady before we knew him.
If your smooth brain doesn't understand who Arkady is, I can't help you. Just focus, ask questions, model it, ask your favorite LLM, do what you do. It's in front of you. You need to decide.
So @DanielTNiles is syaing that $NVDA CFO was being bullied into bad deals with neoclouds that didn't align with strategy by Jensen.
Others say that $NVDA market share is declining rapidly so the response will be to cut off the channels they have nurtured.
Dan Niles @DanielTNiles on what Jensen’s exit means for the AI trade
“He’s now gone. So that’s awesome for OpenAI and Anthropic and their ability to get regulatory capture. But it’s horrible for the neoclouds. Bank of NVIDIA is going to be closed for a bit as Colette, who I believe is an excellent CFO, she's going to more closely examine all those deals and the circular financing.”
Chapters
00:00 Is the AI selloff really unprecedented?
00:50 The dot-com comparison and three phases of AI
02:22 Falling token costs and the open-source effect
03:19 Jensen’s exit and the “Bank of Nvidia”
04:15 Can prepayments protect the neoclouds?
05:31 SoftBank’s writedown: warning sign or exception?
07:20 Is AI demand different this time?
09:16 Interest rates, financing and the AI trade
11:36 Anthropic’s IPO and the risk of an AI duopoly
12:54 Slowing growth and rising losses at the AI labs
13:25 Why Dan prefers Anthropic to OpenAI
1,012
Shorts... If $CRWV earnings result in today's move, what do you think is going to happen when Arkady gets his shot with $NBIS tomorrow. Better cover today.
$NBIS is a winner. Can't you see it? Too many FinTwit thesis, wasted words. Jensen has SCREAMED it to you. He knew Arkady before we knew him.
If your smooth brain doesn't understand who Arkady is, I can't help you. Just focus, ask questions, model it, ask your favorite LLM, do what you do. It's in front of you. You need to decide.
1
1
297
$CMPS doesn't need to win the final patent case quickly to impair Usona. The existence of a credible infringement case can contaminate the entire Usona commercial chain—partner, distributor, inventory financing, clinics and potentially other counterparties—before final judgment.
3
452
$UNCY CMS is removing the Hypercalcemia reporting measure and replacing it with the Hyperphosphatemia clinical measure beginning with PY 2029. The Hyperphosphatemia clinical measure will help drive decreases in cardiovascular complications, hospitalizations, and overall mortality by incentivizing additional interventions such as nutritional counseling, phosphorus binding medications, or adjustment of dialysis prescription. Compared to the Hypercalcemia reporting measure, the Hyperphosphatemia clinical measure will more directly assess patient-focused clinical outcomes.
1
4
737
For Ives to post this is either mad psyops or bullish $nbis
The robust numbers from Meta and SpaceX is the 1-2 punch that speaks volumes around the massive demand/GPU/datacenter Capex for the next year around the AI Revolution. Jitters heading into earnings from CoreWeave bonds were just answered “loud and clear” from tech stalwarts 🐂🎯
8
3,581
$NBIS is a winner. Can't you see it? Too many FinTwit thesis, wasted words. Jensen has SCREAMED it to you. He knew Arkady before we knew him.
If your smooth brain doesn't understand who Arkady is, I can't help you. Just focus, ask questions, model it, ask your favorite LLM, do what you do. It's in front of you. You need to decide.











